{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:37:02Z","timestamp":1782830222745,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["32774"],"award-info":[{"award-number":["32774"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.euf.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:35:26Z","timestamp":1604151326000},"page":"1044-1051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Kassim","family":"Kourbanhoussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McMartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lodde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Zlotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-5787","authenticated-orcid":false,"given":"Paul","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2020.10.002_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.juro.2017.11.150","article-title":"Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis","volume":"200","author":"Uhlig","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0010","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1038\/s41598-017-04083-z","article-title":"The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: national estimates from 33 countries","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.euf.2020.10.002_bib0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2013.11.040","article-title":"Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients","volume":"66","author":"Kluth","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2013.04.010","article-title":"Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries","volume":"32","author":"Donsky","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.euf.2017.08.007","article-title":"Gender-specific differences in recurrence of non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Uhlig","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2020.10.002_bib0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MOU.0000000000000660","article-title":"Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion","volume":"29","author":"Sadighian","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/tau.2018.11.06","article-title":"Review on gender differences in non-muscle invasive bladder cancer","volume":"8","author":"Bilski","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0045","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.euf.2020.10.002_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euf.2020.10.002_bib0055","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1530\/ERC-17-0493","article-title":"Sex steroids in the tumor microenvironment and prostate cancer progression","volume":"25","author":"Boibessot","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.euf.2020.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3389\/fimmu.2018.01269","article-title":"The confluence of sex hormones and aging on immunity","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.euf.2020.10.002_bib0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/08830185.2015.1018417","article-title":"Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium","volume":"34","author":"Mirandola","year":"2015","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.euf.2020.10.002_bib0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","article-title":"Comprehensive characterization of molecular differences in cancer between male and female patients","volume":"29","author":"Yuan","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euf.2020.10.002_bib0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.euo.2020.02.010","article-title":"Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences","volume":"3","author":"de Jong","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0085","first-page":"423","article-title":"Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"35","author":"Sanguedolce","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.euf.2020.10.002_bib0090","article-title":"Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival","author":"Toren","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00256185","article-title":"Effect of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine","volume":"3","author":"Okajima","year":"1975","journal-title":"Urol Res"},{"key":"10.1016\/j.euf.2020.10.002_bib0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/djk113","article-title":"Promotion of bladder cancer development and progression by androgen receptor signals","volume":"99","author":"Miyamoto","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2020.10.002_bib0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000474484","article-title":"Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats","volume":"31","author":"Imada","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0110","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ajpath.2013.01.018","article-title":"Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor","volume":"182","author":"Hsu","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.euf.2020.10.002_bib0115","article-title":"Distinct CD8+ T cell programming in the tumor microenvironment contributes to sex bias in bladder cancer outcome","author":"Kwon","year":"2020","journal-title":"bioRxiv (pre-print)"},{"key":"10.1016\/j.euf.2020.10.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.05.016","article-title":"Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth","volume":"34","author":"Kawahara","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/ijo.2016.3781","article-title":"Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression","volume":"50","author":"Kameyama","year":"2017","journal-title":"Int J Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0130","doi-asserted-by":"crossref","first-page":"49169","DOI":"10.18632\/oncotarget.9994","article-title":"Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer","volume":"7","author":"Kashiwagi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2020.10.002_bib0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.urolonc.2019.03.008","article-title":"Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder","volume":"37","author":"Tyagi","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1464-410X.2010.09834.x","article-title":"Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study","volume":"108","author":"Mir","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.10.002_bib0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.urology.2004.03.025","article-title":"Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer","volume":"64","author":"Boorjian","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.10.002_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12885-019-5512-9","article-title":"Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer","volume":"19","author":"Yasui","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2020.10.002_bib0160","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2020.10.002_bib0165","article-title":"Androgen suppression therapy is associated with lower recurrence of non\u2013muscle-invasive bladder cancer","author":"Wu","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2020.10.002_bib0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/BLC-190262","article-title":"Does 5-alpha reductase inhibitor use improve the efficacy of intravesical bacille Calmette-Gu\u00e9rin (BCG) for non-muscle invasive bladder cancer?","volume":"6","author":"Al-Hogbani","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euf.2020.10.002_bib0175","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1016\/j.clgc.2019.07.016","article-title":"The use of 5-alpha reductase inhibitors prior to radical cystectomy - do they render high-grade bladder tumors less aggressive?","volume":"17","author":"McMartin","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2020.10.002_bib0180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.juro.2016.08.006","article-title":"Suppressed recurrent bladder cancer after androgen suppression with androgen deprivation therapy or 5\u03b1-reductase inhibitor","volume":"197","author":"Shiota","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.juro.2018.04.082","article-title":"Bladder cancer survival of men receiving 5\u03b1-reductase inhibitors","volume":"200","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0190","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.18632\/oncotarget.2851","article-title":"Androgen deprivation therapy prevents bladder cancer recurrence","volume":"5","author":"Izumi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2020.10.002_bib0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1158\/1055-9965.EPI-12-1137","article-title":"Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies","volume":"22","author":"Wallner","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2020.10.002_bib0200","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00345-018-2504-3","article-title":"The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer","volume":"37","author":"Moschini","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2015.08.029","article-title":"Finasteride reduces risk of bladder cancer in a large prospective screening study","volume":"69","author":"Morales","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.10.002_bib0210","doi-asserted-by":"crossref","first-page":"14710","DOI":"10.18632\/oncotarget.3817","article-title":"Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy","volume":"6","author":"Shiota","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2020.10.002_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.03.020","article-title":"Finasteride does not prevent bladder cancer: a secondary analysis of the Medical Therapy for Prostatic Symptoms Study","volume":"36","author":"Sathianathen","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2020.10.002_bib0220","first-page":"6893","article-title":"The genomic alterations of 5\u03b1-reductases and their inhibitor finasteride\u2019s effect in bladder cancer","volume":"37","author":"Chen","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.euf.2020.10.002_bib0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.0.1470467","article-title":"Comparison of high-dose finasteride (5 mg\/day) versus low-dose finasteride (2.5 mg\/day) in the treatment of hirsutism","volume":"147","author":"Bayram","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2020.10.002_bib0230","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1158\/1055-9965.EPI-12-0695","article-title":"Associations of serum sex steroid hormone and 5\u03b1-androstane-3\u03b1,17\u03b2-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride","volume":"21","author":"Kristal","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2020.10.002_bib0235","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1464-410X.2010.09726.x","article-title":"Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer","volume":"107","author":"Wadhwa","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2020.10.002_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2016.05.017","article-title":"Association of aromatase with bladder cancer stage and long-term survival: new insights into the hormonal paradigm in bladder cancer","volume":"15","author":"Nguyen","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2020.10.002_bib0245","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2020.10.002_bib0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920302868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920302868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:52:14Z","timestamp":1762498334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456920302868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2405456920302868"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2020.10.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}